1Gunderson LL,Sargent DJ,Tepper JE,et al.Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer:a pooled analysis[J].J Clin Oncol,2004,22:1785-1796.
1Diaz Rubio E, Evans TR, Tabemero J, et al. Capecitabine (Xeloda) in combination with oxaliplatin : a phase I , dose - escalation study in patients with advanced or metastatic solid tumors [ J ]. Ann Oncol, 2002,13 (4) :558 - 565.
2Hoff PM,Ansari R,Batist G,et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first - line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase Ⅲ study [ J ]. J Clin Oncol, 2001,19 ( 8 ) : 2282 - 2292.
3Kouroussis C, Souglakos J, Kakolyris S, et al. Oxaliplatin in combination with infusional 5 - fluomuracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer:a phase Ⅱ study[ J]. Oncology, 2001,61 ( 1 ) :36 -41.
4Carrato A, Gallego J, Diaz Rubio E. Oxaliplatin:resuhs in colorectal carcinoma[J]. Crit Rev Oncol Hematol,2002,44( 1 ) :29 -44.
5Porschen R, Arkenau HT, Kubicka S, et al. Phase Ⅲ study of capecitabine plus oxaliplatin compared with fluomuracil and leucovorin plus oxaliplatin in metastatic colorectal cancer:a final report of the AIO Colorectal Study Group [ J 1. J Clin Oncol, 2007,25 (27) :4217 -4223.
6Diaz Rubio E, Tabernero J, Gomez Espana A, et al. Phase Ⅲ study of capecitabine plus oxaliplatin compared with continuous - infusion fluorouracil plus oxaliplatin as first -line therapy in metastatic colorectal cancer:final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial [ J ]. J Clin Oncol,2007, 25 (27) :4224 - 4230.
7Marks J,Karachristes A,Marks G,et al.Neoadjurant therapy in rectal cancer patients peraits conversion from permanent colostomy to sphineter-preservation surgery.Proc ASCO,2002 21:168a,Abst 670.
8Wong SJ,Sadasiwan C,Erickson B,et al.A phase Ⅱ trial of preoperative capecitabine and concurrent radiation for locally advanced rectal cancer.Proc ASCO,2004,23:312,Abst 3771.
9Gunderson LL,Sargent DJ,Tepper JE,et al.Impact of T and N stage and treatment on Survival and relapse in adjuvant cancer:A pooled analysis.J Clin Oncot,2004,22(10):1785-1796.
10Roh MS,Colangelo L,asieand S,et al.Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum.Proc ASCO,2004,23:247,Abst 3505.
10Dunst J,Reese T, SutterT, et al. Phase I trial evalua- ting the coneurren combination of radio- therapy and capecitabine in rectal eaneer[J]. J Clin Oncol,2012, 20 (19) : 3983-3991.
